Impact of highly active antiretroviral therapy (HAART) on the incidence of bacterial infections in HIV-infected subjects

Journal of Chemotherapy

Volumn 15, Issue 1, 2003, Pages 60-65

  De Gaetano Donati, Katleen ^a   Tumbarello, M ^a   Tacconelli, E ^a   Bertagnolio, S ^a   Rabagliati, R ^a,b   Scoppettuolo, G ^a   Citton, R ^a   Cataldo, M ^a   Rastrelli, E ^a   Fadda, G ^a   Cauda, R ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Bacteremia; Bacterial infections; Bacterial pneumonia; HAART; HIV infection; UTI

Indexed keywords

ANTIVIRUS AGENT; DIDANOSINE; INDINAVIR; LAMIVUDINE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; RISK FACTOR; STANDARD; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION;

EID: 0037298960     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2003.15.1.60     Document Type: Article

References (20)

1. Witt DJ, Craven DE, McCabe WR. Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS related complex. Am J Med 1987; 82: 900-6.
2. nd ed. New York: Raven Press. 1992: 269-75.
3. Omenaca C, Turett G, Yarrish R et al. Bacteremia in HIV-infected patients: short-term predictors of mortality. J Acquir Immune Defic Syndr 1999; 22: 155-60.
4. Tumbarello M, Tacconelli E, Caponera S, Cauda R, Ortona L. The impact of bacteraemia on HIV infection. Nine years experience in a large Italian University hospital. J Infect 1995; 31: 123-31.
5. Noskin GA, Glassroth J. Bacterial pneumonia associated with HIV-1 infection. Clin Chest Med 1996; 17: 713-23.
6. Tumbarello M, Tacconelli E, de Gaetano K et al. Bacterial pneumonia in HIV-infected patients. Analysis of risk factors and prognostic indicators. J Acquit Immune Defic Syndr 1998; 18: 39-45.
7. Schonwald S, Begovac J, Skerk V. Urinary tract infections in HIV disease. Int J Antimicrob Agents 1999; 11: 309-11.
8. Tumbarello M, Tacconelli E, de Gaetano Donati K et al. Nosocomial bloodstream infections in HIV-infected patients: attributable mortality and excess of hospital stay. J Acquit Immune Defic Syndr 1998; 19: 490-6.
9. th ed. Philadelphia-New York: Lippincott-Raven 1997: 259-65.
10. Deeks SG, Smith M, Holodniy, Kahn JO. HIV-1 protease inhibitors. A review for clinicians. JAMA 1997; 277: 145-53.
11. Jacobson MA, French M. Altered natural history of AIDS-related opportunistic infections in the era of potent combination of antiretroviral therapy. AIDS 1998; 12: S157-63.
12. Paul S, Gilbert HM, Ziecheck W, Jacobs J, Sepkowitz KA. The impact of potent antiretroviral therapy on the characteristics of hospitalised patients with HIV infection. AIDS 1999; 13: 415-8.
13. Garner JS, Jarvis WR, Emoti TG. CDC definition for nosocomial infections. Am J Infect Control 1988; 16: 128-40.
14. Knaus WA, Wagner DP, Draper EA et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalised adults. Chest 1991; 100: 1619-36.
15. Mouton Y, Alfandari S, Valette F et al. Impact of protease inhibitors on AIDS-defining events and hospitalisations in 10 French AIDS reference centres. AIDS 1997; 12: F101-5.
16. Ledergerber B, Egger M, Erard V, et al. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA 1999; 282: 2220-6.
17. Tacconelli E, Tumbarello M, de Gaetano K, Cauda R, Ortona L. Highly active antiretroviral therapy decreases the incidence of bacteraemia in Human Immunodeficiency Virus-infected individuals. Clin Infect Dis 1998; 27: 901-2.
18. Tumbarello M, Tacconelli E, de Gaetano Donati K, Cauda R. HIV-associated bacterial pneumonia in the era of Highly Active Antiretroviral Therapy. J Acquir Immune Def Syndr 1999; 20: 208-9.
19. Mertins SD, Cauda R. The role of polymorphonuclear leukocytes in infection by retrovirus with emphasis on the human immunodeficiency virus. Viral Immunol 1990; 3: 173-7.
20. Tumbarello M, Tacconelli E, de Gaetano Donati K et al. Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome. Eur Respir J 2001; 17: 636-40.